Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01532544
Recruitment Status : Terminated (Difficulty recruiting patients, company closed down)
First Posted : February 14, 2012
Last Update Posted : April 22, 2016
Anders Perner
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Thrombologic ApS

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2014
  Study Completion Date : March 2014